Sensex turn flat after reclaiming 52k: Key factors driving D-St today
SECTIONS
Last Updated: Jun 01, 2021, 11:51 AM IST
Share
Synopsis
The ongoing bull run in the market has taken even the incorrigible optimists by surprise. FIIs, regarded as smart investors, have been caught on the wrong foot.
The fact that India VIX is at a 52- week low also indicates the resilience of the market, said an analyst.
Related
NSE
Explore Now
NEW DELHI: Buying in bank and auto stocks lifted benchmark indices to another high on Tuesday as better-than-expected GDP numbers gave hopes to investors but soon profit booking kicked in and indices turned flat.
Rossari Biotech reported a 47.1% jump in consolidated net profit to Rs 22.2 crore on a 36.8% rise in net sales to Rs 218.22 crore in Q4 FY21 over Q4 FY20.On a consolidated basis, profit before tax jumped 46.3% to Rs 29.91 crore in Q4 FY21 as against Rs 20.44 crore registered in Q4 FY20.
During the quarter, the company successfully commissioned all phases of its greenfield manufacturing facility at Dahej, Gujarat. The unit has a total installed capacity 132,500 MTPA, enhancing the total capacity of Rossari by 2.1 times to 252,500 MTPA. The company expects to sustainably ramp-up utilization levels at the Dahej unit over the next 3-4 years.
Rossari Biotech posts 37 pc revenue growth at Rs 218 crore ANI | Updated: May 15, 2021 11:03 IST
Mumbai (Maharashtra) [India], May 15 (ANI): Speciality chemicals manufacturer Rossari Biotech has posted 37 per cent increase in its revenues from operations during the quarter ended March at Rs 218 crore as against Rs 160 crore in the year-ago period.
Earnings before interest, taxes, depreciation and amortisation (EBITDA) moved up 47 per cent to Rs 35 crore from Rs 24 crore.
Profit after tax too jumped by 47 per cent to Rs 22 crore in Q4 FY21 from Rs 15 crore in Q4 FY20. Earnings per share stood at Rs 4.29 as against Rs 3.06.
Chairman Edward Menezes and Managing Director Sunil Chari said the growth was primarily driven by a robust and continued uptick in sales in the home, personal care and performance chemicals (HPCC) segment led by higher offtake in hygiene products and anti-viral portfolio sales.
Read more about Rossari Biotech consolidated net profit rises 48.54% in the March 2021 quarter on Business Standard. Sales rise 36.77% to Rs 218.22 crore